Health Care • Medical/Dental Instruments
$168.65 ▲ +2.26
(+1.36%)
MKT CAP: $4.22B • VOL: 202.5K
52W L $113 52W H $193
ROARABLE / RQD
D+ • 55/100
PIOTROSKI
8 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$142
MEDIAN
$189
MEAN
$192
HIGH
$229
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ICUI TAPE
ICUI // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $204.07 | $193.95 | 2025-02-14 | $153.47 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $212.50 | $199.01 | 2025-02-06 | $158.53 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $192.26 | $185.52 | 2025-01-29 | $161.90 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $172.02 | — | 2025-01-17 | $165.28 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $148.41 | $160.22 | 2025-01-09 | $150.10 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $200.69 | $175.40 | 2024-12-18 | $146.73 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $163.59 | $170.34 | 2024-12-04 | $156.84 | -4.3% | 48% | C |